Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

157
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
157
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

1.5K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.5K
Controls in Experiments01:13

Controls in Experiments

14.6K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinothorax and Empyema: Presentation of an Unusual Complication of a Rare Condition.

Case reports in pulmonology·2026
Same author

Clinical Spectrum and Outcomes of Cryptogenic <i>Klebsiella pneumoniae</i> Liver Abscess in the Americas: A Scoping Review.

Pathogens (Basel, Switzerland)·2023
Same author

ProtekDuo as a bridge to lung transplant and heart-lung transplant.

Clinical transplantation·2021
Same author

Coronary artery disease in lung transplant patients.

Clinical transplantation·2020
Same author

Sequential battery of COVID-19 testing to maximize negative predictive value before surgeries.

Revista do Colegio Brasileiro de Cirurgioes·2020

Related Experiment Video

Updated: Dec 24, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.7K

Hydroxychloroquine and COVID-19.

Neeraj Sinha1, Galit Balayla2

  • 1Pulmonary Transplant, University of Miami Miller School of Medicine, Miami, Florida, USA nsinhamd@yahoo.com.

Postgraduate Medical Journal
|April 17, 2020
PubMed
Summary

Hydroxychloroquine and chloroquine, antimalarial drugs, show promise as antivirals. Research explores their potential to combat the COVID-19 pandemic due to their known anti-inflammatory and antiviral properties.

Keywords:
thoracic medicine

More Related Videos

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

14.1K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

Related Experiment Videos

Last Updated: Dec 24, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.7K
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

14.1K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

Area of Science:

  • Pharmacology
  • Virology
  • Infectious Diseases

Background:

  • Hydroxychloroquine and chloroquine are established antimalarial drugs.
  • These medications possess anti-inflammatory and antiviral properties, leading to their use in chronic conditions like systemic lupus erythematosus.
  • Their antiviral mechanisms have garnered research interest, particularly concerning novel respiratory viruses.

Purpose of the Study:

  • To review the historical context and mechanisms of action of hydroxychloroquine and chloroquine.
  • To evaluate the potential application of these drugs in managing the COVID-19 pandemic.

Main Methods:

  • Literature review of existing studies on hydroxychloroquine and chloroquine.
  • Analysis of in vitro and in vivo research data concerning their antiviral effects.
  • Examination of studies related to severe acute respiratory syndrome virus (SARS-CoV) and 2019 novel coronavirus (COVID-19).

Main Results:

  • In vitro studies demonstrate the efficacy of hydroxychloroquine and chloroquine against SARS-CoV.
  • Ongoing in vitro and in vivo investigations are assessing their impact on COVID-19.
  • The drugs exhibit a favorable safety profile in managing chronic inflammatory diseases.

Conclusions:

  • Hydroxychloroquine and chloroquine present a potential therapeutic avenue for COVID-19, supported by their known antiviral actions.
  • Further research is warranted to fully elucidate their efficacy and safety in the context of the COVID-19 pandemic.